作者: Robert Sackstein , Karin Hoffmeister , Qiyong Peter Liu
DOI:
关键词:
摘要: The present invention relates to a platelet additive solution (PAS) having an amount of one or more β-galactosidase inhibitors with without sialidase inhibitors, and optionally glycan-modifying agents; PAS components that include salt, citrate source, carbon any combination thereof.